Loading...

The Cannabist Company Holdings Inc.

CBST.NENEO
HealthcareDrug Manufacturers - Specialty & Generic
CA$0.07
CA$0.01(15.38%)

The Cannabist Company Holdings Inc. CBST.NE Peers

See (CBST.NE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CBST.NECA$0.08+15.38%36M-0.25-CA$0.30N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$6.36+1.11%2.4B-37.41-CA$0.17N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
GTII.CNCA$7.11-1.11%1.7B24.52CA$0.29N/A
TRUL.CNCA$5.44-0.18%1B-4.99-CA$1.09N/A
CRON.TOCA$2.65-0.38%1B13.95CA$0.19N/A
CURA.TOCA$1.20+5.26%908.8M-2.61-CA$0.46N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
DHT-UN.TOCA$13.02-0.69%733.2M325.50CA$0.04+3.90%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CBST.NE vs CURA.CN Comparison

CBST.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CBST.NE stands at 36M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, CBST.NE is priced at CA$0.08, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CBST.NE currently has a P/E ratio of -0.25, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, CBST.NE's ROE is +10.11%, compared to CURA.CN's ROE of -0.25%. Regarding short-term risk, CBST.NE is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for CBST.NE.

Stock Price Comparison

Loading...

Frequently Asked Questions